BriaCell Therapeutics(BCTX)
$3.59-0.10 (-2.71%)
BCTX
BriaCell Therapeutics ownership
$3.59
At close:-0.10 (-2.71%)
BriaCell Therapeutics (BCTX) Ownership - Who Owns BriaCell Therapeutics?
336 Followers
BriaCell Therapeutics (BCTX) Ownership Overview
- 32.28% Insiders
- 0.04% Mutual Funds
- 0.74% Other Institutional Investors
- 66.94% Public Companies and Individual Investors
The ownership structure of BriaCell Therapeutics (BCTX) stock is a mix of institutional, retail, and individual investors. Approximately 0.78% of the company’s stock is owned by Institutional Investors, 32.28% is owned by Insiders, and 66.94% is owned by Public Companies and Individual Investors.
The ownership structure of BriaCell Therapeutics (BCTX) stock is a mix of institutional, retail, and individual investors. Approximately 0.78% of the company’s stock is owned by Institutional Investors, 32.28% is owned by Insiders, and 66.94% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 24, 2026 | Marc Lustig | C$344,294 | |
| Sep 24, 2026 | Marc Lustig | C$7,845,000 | |
| Sep 24, 2026 | Marc Lustig | C$67,740 | |
| Nov 26, 2025 | Marc Lustig | C$29,945 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Marc Lustig | 2,547,822 | Insider | 29.18% | 9,146,681 |
| William Williams | 119,992 | Insider | 1.37% | 430,771 |
| Giuseppe Del Priore | 75,356 | Insider | 0.86% | 270,528 |
| Gadi Levin | 37,695 | Insider | 0.43% | 135,325 |
| Miguel A Lopez-lago | 37,676 | Insider | 0.43% | 135,257 |
| Fidelity Concord Street Trust | 3,231 | Institution | 0.04% | 11,599 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 3,231 | Institution | 0.04% | 11,599 |
FAQ
Who Owns BriaCell Therapeutics (BCTX)?
According to the latest TipRanks data, approximately 0.78% of the company's stock is held by institutional investors, 32.28% is held by insiders, and 66.94% is held by public companies and individual investors.
What percentage of BriaCell Therapeutics (BCTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.78% of BriaCell Therapeutics (BCTX) stock is held by institutional investors: 0.04% by mutual funds and 0.74% by other institutional investors.
What percentage of BriaCell Therapeutics (BCTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.94% of BriaCell Therapeutics (BCTX) stock is held by public companies and individual investors.
Who owns the most shares of BriaCell Therapeutics (BCTX)?
Marc Lustig owns the most shares of BriaCell Therapeutics (BCTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
